COBAS® CMV
Mexico·Clase II·III. DIAGNOSTIC AGENTS·PRODUCTOSROCHE, S.A. DE C.V.·Registered February 22, 2022LA PRUEBA COBAS® CMV ES UNA PRUEBA DEAMPLIFICACIÓNDEÁCIDOSNUCLEICOSINVITROPARALAMEDICIÓNCUANTITATIVADELADNDELCITOMEGALOVIRUS(CMV) EN PLASMA HUMANO CONSERVADO EN EDTA.AGENTESDEDIAGNÓSTICOPARAUSOINVITRO.PARAUSOEXCLUSIVO EN LABORATORIOS CLÍNICOS Ó DE GABINETE.
THE COBAS® CMV TEST IS A TEST FOR AMPLIFICATION OF NUCLEIC ACIDSINVITROPARALAM QUANTITATIVE ANALYSIS OF CYTOMEGALOVIRUS (CMV) IN HUMAN PLASMA CONSERVED IN EDTA. DIAGNOSTICAGENTSFORUSEINVITRO. FOR EXCLUSIVE USE IN CLINICAL OR CABINET LABORATORIES.
- Risk Class / Clase de Riesgo
- Clase II
- Product Type (Spanish)
- III. AGENTES DE DIAGNÓSTICO
- Product Type (English)
- III. DIAGNOSTIC AGENTS
- Trade Name (Spanish)
- PRUEBADEAMPLIFICACIÓNDEÁCIDOS NUCLEICOS PARA LAMEDICIÓN DEL ADN DELCITOMEGALOVIRUS (CMV).
- Trade Name (English)
- NUCLEIC ACID AMPLIFICATION TEST FOR MEASURING THE DNA OF CYTOMEGALOVIRUS (CMV).
- Analysis ID
- 139R2022 SSA
- Registration Date
- February 22, 2022
- Name (Spanish)
- PRODUCTOSROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOSROCHE, S.A. DE C.V.
Access comprehensive regulatory information for COBAS® CMV (COBAS® CMV) in the Mexico medical device market through Pure Global AI's free database. This Clase II medical device is registered under COFEPRIS analysis ID 139R2022 SSA and manufactured by PRODUCTOSROCHE, S.A. DE C.V.. The device was registered on February 22, 2022.
This page provides complete registration details including product type (III. DIAGNOSTIC AGENTS), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.